Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
$40.51
+0.5%
$4.11
$0.28
$17.38
$1.28B3.65373,201 shs105 shs
JULD
Premium Income 10 Barrier ETF
$24.84
-1.6%
$25.11
$22.87
$25.54
$5.69M0.281,793 shsN/A
NOVP
PGIM S&P 500 Buffer 12 ETF - November
$28.69
+0.1%
$27.95
$24.64
$28.81
$5.46MN/A620 shs2,790 shs
OQAL
Invesco Russell 1000 Quality Factor ETF
$28.39
$28.39
$0.00
$0.00
N/AN/AN/A300 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
+0.28%+0.47%+3.55%+15.10%+872.26%
JULD
Premium Income 10 Barrier ETF
0.00%0.00%-1.68%+2.90%-0.48%
NOVP
PGIM S&P 500 Buffer 12 ETF - November
+0.05%-0.17%+2.45%+11.44%+11.76%
OQAL
Invesco Russell 1000 Quality Factor ETF
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
JULD
Premium Income 10 Barrier ETF
N/AN/AN/AN/AN/AN/AN/AN/A
NOVP
PGIM S&P 500 Buffer 12 ETF - November
N/AN/AN/AN/AN/AN/AN/AN/A
OQAL
Invesco Russell 1000 Quality Factor ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
0.00
N/AN/AN/A
JULD
Premium Income 10 Barrier ETF
0.00
N/AN/AN/A
NOVP
PGIM S&P 500 Buffer 12 ETF - November
0.00
N/AN/AN/A
OQAL
Invesco Russell 1000 Quality Factor ETF
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/AN/AN/AN/A$0.95 per shareN/A
JULD
Premium Income 10 Barrier ETF
N/AN/AN/AN/AN/AN/A
NOVP
PGIM S&P 500 Buffer 12 ETF - November
N/AN/AN/AN/AN/AN/A
OQAL
Invesco Russell 1000 Quality Factor ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
-$40.86MN/A0.00N/AN/A-81.29%-56.92%N/A
JULD
Premium Income 10 Barrier ETF
N/AN/A24.02N/AN/AN/AN/AN/A
NOVP
PGIM S&P 500 Buffer 12 ETF - November
N/AN/A0.00N/AN/AN/AN/AN/A
OQAL
Invesco Russell 1000 Quality Factor ETF
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/AN/AN/AN/AN/A
JULD
Premium Income 10 Barrier ETF
$1.947.81%N/AN/AN/A
NOVP
PGIM S&P 500 Buffer 12 ETF - November
N/AN/AN/AN/AN/A
OQAL
Invesco Russell 1000 Quality Factor ETF
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Edge Therapeutics, Inc. stock logo
EDGE
Edge Therapeutics
N/A31.51 millionN/ANot Optionable
JULD
Premium Income 10 Barrier ETF
N/A225,000N/ANot Optionable
NOVP
PGIM S&P 500 Buffer 12 ETF - November
N/A190,001N/AN/A
OQAL
Invesco Russell 1000 Quality Factor ETF
N/AN/AN/ANot Optionable

Recent News About These Companies

Invesco Russell 1000 Dynamic-Multifactor Index ETF (IUMF)
Russell 1000 Quality Factor Ind (^ESGU)

Top Headlines

View All Headlines
Edge Therapeutics stock logo

Edge Therapeutics NASDAQ:EDGE

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.

Premium Income 10 Barrier ETF BATS:JULD

$24.84 -0.41 (-1.62%)
Closing price 07/1/2025
Extended Trading
$24.84 0.00 (0.00%)
As of 07/1/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Innovator Premium Income 10 Barrier ETF - July (JULD) is an exchange-traded fund that is based on the S&P 500 Price Return index. The fund seeks to provide a consistent income stream and a limited protective barrier against losses over a one-year period. The actively managed fund holds a package of S&P 500 FLEX options and US Treasurys JULD was launched on Jul 3, 2023 and is managed by Innovator.

PGIM S&P 500 Buffer 12 ETF - November BATS:NOVP

$28.68 +0.01 (+0.05%)
As of 07/17/2025 09:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The PGIM S&P 500 Buffer 12 ETF - November (NOVP) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPDR S&P 500 ETF Trust over a specific holdings period. The actively managed fund holds options and collateral. NOVP was launched on May 21, 2024 and is issued by PGIM.

Invesco Russell 1000 Quality Factor ETF BATS:OQAL

$28.39 0.00 (0.00%)
As of 02/14/2020